Form 4 for IRMD IRADIMED CORP
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-11 · accession 0000898432-22-000100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-11 | 2022-02-11 | IRMD | Scott Christopher K. | CFO, Sec | S - Sale | $50.06 | -19.3K | 13.7K | -58% | -$965.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-11 | S | D | 19,286 | $50.06 | 13,710 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $50.00 to $50.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected. |